159 related articles for article (PubMed ID: 27173669)
21. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
Shen J; Pan JW; Fan ZX; Xiong XX; Zhan RY
J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
[TBL] [Abstract][Full Text] [Related]
22. Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis.
Kramer A; Fletcher J
Stroke; 2009 Oct; 40(10):3403-6. PubMed ID: 19679843
[TBL] [Abstract][Full Text] [Related]
23. The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage.
Wijdicks EF; Vermeulen M; van Brummelen P; van Gijn J
Clin Neurol Neurosurg; 1988; 90(3):209-14. PubMed ID: 3197346
[TBL] [Abstract][Full Text] [Related]
24. Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study.
Onichimowski D; Nosek K; Goraj R; Jalali R; Wińska A; Pawlos A; Tuyakov B
Drug Des Devel Ther; 2018; 12():1777-1783. PubMed ID: 29950812
[TBL] [Abstract][Full Text] [Related]
25. Fludrocortisone evaluation in aneurysmal subarachnoid hemorrhage patients with cerebral salt wasting (Flush Salt).
Elledge SR; Shewmaker JW; Yang S; Blunck JR
Clin Neurol Neurosurg; 2023 Feb; 225():107568. PubMed ID: 36608470
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol-Reducing Agents for Treatment of Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Akhigbe T; Zolnourian A; Bulters D
World Neurosurg; 2017 May; 101():476-485. PubMed ID: 28192263
[TBL] [Abstract][Full Text] [Related]
27. [Increased urinary sodium excretion in the early phase of aneurysmal subarachnoid hemorrhage as a predictor of cerebral salt wasting syndrome].
Nakagawa I; Kurokawa S; Takayama K; Wada T; Nakase H
Brain Nerve; 2009 Dec; 61(12):1419-23. PubMed ID: 20034309
[TBL] [Abstract][Full Text] [Related]
28. Hyponatremia is predictable in patients with aneurysmal subarachnoid hemorrhage--clinical significance of serum atrial natriuretic peptide.
Nakagawa I; Kurokawa S; Nakase H
Acta Neurochir (Wien); 2010 Dec; 152(12):2147-52. PubMed ID: 20680650
[TBL] [Abstract][Full Text] [Related]
29. Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage.
Jang YG; Ilodigwe D; Macdonald RL
Neurocrit Care; 2009; 10(1):141-7. PubMed ID: 18810661
[TBL] [Abstract][Full Text] [Related]
30. Administration of hypertonic (3%) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage.
Suarez JI; Qureshi AI; Parekh PD; Razumovsky A; Tamargo RJ; Bhardwaj A; Ulatowski JA
J Neurosurg Anesthesiol; 1999 Jul; 11(3):178-84. PubMed ID: 10414672
[TBL] [Abstract][Full Text] [Related]
31. Fluid loading in rats increases serum brain natriuretic peptide concentration.
Inoha S; Inamura T; Nakamizo A; Matushima T; Ikezaki K; Fukui M
Neurol Res; 2001 Jan; 23(1):93-5. PubMed ID: 11210439
[TBL] [Abstract][Full Text] [Related]
32. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature.
Velat GJ; Kimball MM; Mocco JD; Hoh BL
World Neurosurg; 2011 Nov; 76(5):446-54. PubMed ID: 22152574
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for meningitis after craniotomy in patients with subarachnoid hemorrhage due to anterior circulation aneurysms rupture.
Inoue T; Shimizu H; Fujimura M; Sato K; Endo H; Niizuma K; Sakata H; Tominaga T
Clin Neurol Neurosurg; 2015 Dec; 139():302-6. PubMed ID: 26562195
[TBL] [Abstract][Full Text] [Related]
34. Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: a survey of European practice.
Velly LJ; Bilotta F; Fàbregas N; Soehle M; Bruder NJ; Nathanson MH;
Eur J Anaesthesiol; 2015 Mar; 32(3):168-76. PubMed ID: 25303971
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage.
Rosengart AJ; Schultheiss KE; Tolentino J; Macdonald RL
Stroke; 2007 Aug; 38(8):2315-21. PubMed ID: 17569871
[TBL] [Abstract][Full Text] [Related]
36. Management of hyponatremia and volume contraction.
Rabinstein AA; Bruder N
Neurocrit Care; 2011 Sep; 15(2):354-60. PubMed ID: 21748503
[TBL] [Abstract][Full Text] [Related]
37. In vivo animal models of cerebral vasospasm: a review.
Megyesi JF; Vollrath B; Cook DA; Findlay JM
Neurosurgery; 2000 Feb; 46(2):448-60; discussion 460-1. PubMed ID: 10690735
[TBL] [Abstract][Full Text] [Related]
38. Experimental model for investigating hyponatremia after subarachnoid hemorrhage in rats.
Mori T; Katayama Y; Kojima J; Moro N; Kawai H; Yoneko M; Kawamata T
Acta Neurochir Suppl; 2005; 95():377-80. PubMed ID: 16463885
[TBL] [Abstract][Full Text] [Related]
39. Controlled release of lipopolysaccharide in the subarachnoid space of rabbits induces chronic vasospasm in the absence of blood.
Recinos PF; Pradilla G; Thai QA; Perez M; Hdeib AM; Tamargo RJ
Surg Neurol; 2006 Nov; 66(5):463-9; discussion 469. PubMed ID: 17084186
[TBL] [Abstract][Full Text] [Related]
40. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
